TGFB1 and glioblastoma: Ad-Smad7 also inhibited activation of the BRE-luciferase reporter in these glioblastoma cell lines for both TGF-β and BMP7 stimulation, while additionally inhibiting TGF-β mediated activation of the CAGA12-luciferase reporter (Fig. S4).